Cargando…
Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
Immune-related myocarditis is a severe and even life-threatening immune-related adverse event (irAE) which may also be underestimated due to the challenge in diagnosis. The inherent difference between individuals with immune-associated myocarditis has received little attention. Our study aimed to id...
Autores principales: | Lei, Yanna, Zheng, Xiufeng, Huang, Qian, Li, Xiaoying, Qiu, Meng, Liu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294234/ https://www.ncbi.nlm.nih.gov/pubmed/35865949 http://dx.doi.org/10.3389/fphar.2022.914928 |
Ejemplares similares
-
Drug therapy for myocarditis induced by immune checkpoint inhibitors
por: Wu, Yihao, et al.
Publicado: (2023) -
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
por: Lei, Yanna, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
por: Wang, Li, et al.
Publicado: (2021) -
Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
por: Li, Na, et al.
Publicado: (2023) -
A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis
por: van der Vegt, Solveig A., et al.
Publicado: (2022)